Time to deterioration of symptoms with durvalumab in stage III, locally advanced, unresectable NSCLC: Post-hoc analysis of PACIFIC patient-reported outcomes
No Thumbnail Available
Identifiers
Date
2018-04-01
Authors
Hui, R.
Ozguroglu, M.
Villegas, A.
Daniel, D.
Vicente, D.
Murakami, S.
Ryden, A.
Zhang, Y.
Dennis, P.
Antonia, S.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier science inc
Metrics
Export
